Dimensional Fund Advisors
MRNA icon

Dimensional Fund Advisors’s Moderna MRNA Stock Holding History

Dimensional Fund Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$173M Buy
2,468,775
+336,608
+16% +$17.4M 0.03% 765
2026
Q1 		$108M Buy
2,132,167
+343,216
+19% +$16M 0.02% 1011
2025
Q4 		$52.8M Buy
1,788,951
+987,312
+123% +$26.8M 0.01% 1484
2025
Q3 		$20.7M Sell
801,639
-307,828
-28% -$8.59M ﹤0.01% 1977
2025
Q2 		$30.6M Sell
1,109,467
-421,563
-28% -$11.1M 0.01% 1773
2025
Q1 		$43.5M Sell
1,531,030
-138,257
-8% -$4.91M 0.01% 1545
2024
Q4 		$69.3M Sell
1,669,287
-156,747
-9% -$7.49M 0.02% 1316
2024
Q3 		$122M Buy
1,826,034
+398,734
+28% +$36.6M 0.03% 861
2024
Q2 		$170M Buy
1,427,300
+29,566
+2% +$3.74M 0.04% 539
2024
Q1 		$149M Buy
1,397,734
+90,570
+7% +$9.13M 0.04% 639
2023
Q4 		$130M Sell
1,307,164
-530,849
-29% -$44.6M 0.04% 687
2023
Q3 		$190M Sell
1,838,013
-379,503
-17% -$42.3M 0.06% 354
2023
Q2 		$269M Sell
2,217,516
-342,438
-13% -$45.7M 0.09% 223
2023
Q1 		$393M Buy
+2,559,954
New +$422M 0.13% 119
2022
Q3 		$249M Buy
2,105,551
+847,329
+67% +$129M 0.1% 202
2022
Q2 		$180M Buy
1,258,222
+270,744
+27% +$38.7M 0.06% 346
2022
Q1 		$170M Buy
987,478
+47,755
+5% +$8.04M 0.05% 446
2021
Q4 		$239M Buy
939,723
+315,282
+50% +$92.2M 0.07% 284
2021
Q3 		$240M Buy
624,441
+337,553
+118% +$124M 0.08% 256
2021
Q2 		$67.4M Buy
286,888
+777
+0.3% +$139K 0.02% 1185
2021
Q1 		$37.4M Sell
286,111
-50,433
-15% -$7.31M 0.01% 1655
2020
Q4 		$35.2M Buy
336,544
+74,027
+28% +$7.49M 0.01% 1652
2020
Q3 		$18.6M Buy
262,517
+17,181
+7% +$1.2M 0.01% 1894
2020
Q2 		$15.8M Buy
245,336
+197,679
+415% +$10.8M 0.01% 1987
2020
Q1 		$1.43M Buy
47,657
+14,201
+42% +$327K ﹤0.01% 2810
2019
Q4 		$654K Buy
33,456
+1,501
+5% +$26.6K ﹤0.01% 3092
2019
Q3 		$509K Buy
+31,955
New +$472K ﹤0.01% 3135

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Dimensional Fund Advisors's MRNA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Moderna (MRNA) stake by 16% in Q2 2026, buying an estimated $17.4M and bringing the position to 2,468,775 shares worth $173M. The position accounts for 0.03% of the portfolio, ranked #765.

Dimensional Fund Advisors first reported a position in MRNA in Q3 2019 and has held it in 27 quarters since. The position peaked at $393M in Q1 2023. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Dimensional Fund Advisors held 2,468,775 shares of Moderna worth $173M as of Q2 2026.
  • Dimensional Fund Advisors bought 336,608 Moderna shares in Q2 2026, an estimated $17.4M.
  • Moderna made up 0.03% of Dimensional Fund Advisors's portfolio in Q2 2026, its #765 holding.
  • Dimensional Fund Advisors first reported a position in Moderna in Q3 2019 and has held it in 27 quarters since.
  • Dimensional Fund Advisors's Moderna position peaked at $393M in Q1 2023.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.